Join
Live feed
·
INSIDERFilingvia Quantisnow
Entera Bio Ltd. logo

Chief of R&D Burshtein Gregory was granted 26,316 units of Ordinary Shares, increasing direct ownership by 35% to 101,442 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ENTX· Entera Bio Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENTX (Entera Bio Ltd.) and more on Quantisnow.